rs2253310 — FOXO3
Intronic FOXO3 longevity variant; C allele (minor in East Asians) associated with ~20% lower mortality risk and better cognitive aging in Chinese cohorts; eQTL affecting FOXO3 brain expression
Details
- Gene
- FOXO3
- Chromosome
- 6
- Risk allele
- G
- Consequence
- Intronic
- Inheritance
- Additive
- Clinical
- Protective
- Evidence
- Moderate
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Longevity & AgingSee your personal result for FOXO3
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
FOXO3's East Asian Longevity Signal — An Intronic eQTL With Brain Expression Effects
FOXO3 is the most replicated human longevity gene, with protective variants confirmed across European, Asian, and African populations. While the well-characterized rs2802292 G-allele (the HSF1-binding enhancer variant) has been studied primarily in Western and Japanese-American cohorts, rs2253310 captures a distinct signal that may be especially informative for East Asian populations: here, the longevity-protective C allele is the minority allele (~27% in Japanese), while the less-favorable G allele predominates (~73%). This reversed frequency pattern makes rs2253310 a particularly useful genetic marker for East Asian longevity research.
A 2022 longitudinal study11 A 2022 longitudinal study
Ji JS, Liu L, Yan LL, Zeng Y. Comparing Effects of FOXO3 and Residing
in Urban Areas on Longevity: A Gene-Environment Interaction Study. J Gerontol A Biol Sci Med Sci.
2022 followed 3,085 Chinese older adults and found CC
homozygotes had a 19% lower mortality hazard compared to GG homozygotes (HR 0.808, 95% CI
0.667–0.978), a magnitude comparable to the survival benefit of urban versus rural residence in
the same cohort.
The Mechanism
rs2253310 sits in intron 2 of FOXO3 at chromosomal position 108,567,389 (GRCh38, chromosome 6). The gene is on the plus strand, so no strand-complementing is needed — genome files report the same alleles used in publications. The variant does not alter FOXO3 protein sequence; instead, it acts as an [expression quantitative trait locus (eQTL) | a variant that affects how much of a gene product is made, without changing the protein structure], influencing FOXO3 transcription.
A meta-analysis of four longevity cohorts22 A meta-analysis of four longevity cohorts
Bae H, Gurinovich A, Malovini A, et al. Effects of
FOXO3 Polymorphisms on Survival to Extreme Longevity in Four Centenarian Studies. J Gerontol A
Biol Sci Med Sci. 2018 found that among all 17 tested
FOXO3 variants, rs2253310 and rs6911407 showed the most significant effects on FOXO3 expression
in brain tissue — a key finding given FOXO3's role in neuronal stress resistance, autophagy, and
protection against age-related neurodegeneration.
The rs2253310 G allele's adverse biological direction was confirmed by a 2025 Russian study (n=1,365) showing GG homozygotes face nearly double the risk of chronic obstructive pulmonary disease (OR 1.99, p = 5.93×10⁻⁷) , consistent with lower FOXO3-mediated antioxidant defense in lung tissue of G-allele carriers.
The Evidence
Three independent Chinese longitudinal cohort studies using the Chinese Longitudinal Healthy Longevity Survey demonstrate consistent protective effects of the rs2253310 C allele:
Liu et al. 202133 Liu et al. 2021
Liu L, Zhu A, Shu C, Zeng Y, Ji JS. Gene-Environment Interaction of FOXO and
Residential Greenness on Mortality Among Older Adults. Rejuvenation Res. 2021
studied 3,179 adults aged 65 and older, finding CC homozygotes had an HR of 0.803 (95% CI
0.666–0.968) for all-cause mortality. Notably, the protective effect of residential greenness
was amplified in C-allele carriers, suggesting gene-environment synergy in FOXO3 activation.
Ji et al. 2022 cognitive study44 Ji et al. 2022 cognitive study
Ji JS, Liu L, Zeng Y, Yan LL. Effect of FOXO3 and Air Pollution
on Cognitive Function. J Gerontol A Biol Sci Med Sci. 2022
tracked cognitive function over 14 years and found C-allele homozygotes had higher baseline
MMSE scores and lower odds of cognitive impairment over time. The cognitive protection was
strongest in women, older adults, and those in lower air-pollution environments, suggesting that
the C allele's FOXO3 expression boost matters most when cellular stress is high.
The blood pressure findings from Morris et al. 2016 add a cardiovascular dimension: among 843 Japanese Americans, women carrying two C alleles had 6 mmHg lower systolic and 3 mmHg lower diastolic blood pressure than GG homozygotes, with essential hypertension prevalence of 3.3% vs 9.5% (P = 0.03–0.04). This gender specificity echoes the pattern seen with other FOXO3 longevity variants, where protective effects are often stronger in women.
Practical Implications
The practical takeaways from rs2253310 mirror those of other FOXO3 longevity variants — all of them point toward the same lifestyle levers for activating FOXO3 expression: fasting, exercise, and stress management. The unique contribution of rs2253310 is its cognitive aging signal: the C allele's strongest effects appear in brain tissue eQTLs, suggesting that brain health across the lifespan may be particularly relevant to this variant.
For GG homozygotes — especially prevalent in East Asian populations — the cognitive aging data suggest that interventions targeting neurological resilience deserve particular emphasis: regular aerobic exercise (which strongly activates FOXO3 in neural tissue), sleep optimization (FOXO3 expression cycles with circadian rhythms), and minimizing chronic oxidative stressors such as air pollution exposure and smoking.
Interactions
rs2253310 lies in the same FOXO3 intron 2 region as rs2802292 and is in high linkage disequilibrium with the broader FOXO3 longevity haplotype. In East Asian populations, the LD pattern differs from European cohorts — rs2253310's C allele is uncommon where rs2802292's G allele may be more common, meaning the two variants may be partially independent signals in Asian ancestries, which could explain rs2253310's distinct detection in Chinese cohort studies rather than primarily in European studies.
The gene-environment interactions documented for rs2253310 — with residential greenness, urban living, and air pollution — are not replicated for most other FOXO3 variants, suggesting this particular intronic position may regulate FOXO3 expression in response to environmental oxidative stress in a way that differs mechanistically from the HSF1-dependent rs2802292 enhancer.
Genotype Interpretations
What each possible genotype means for this variant:
Standard FOXO3 expression at this locus without longevity enhancement
The GG genotype at rs2253310 means neither copy of your FOXO3 gene has the intronic C-allele that enhances FOXO3 brain and stress-tissue expression at this eQTL. Studies in Chinese older adults consistently show GG individuals as the higher-mortality reference group, with CC carriers gaining HR benefits of ~0.80 (approximately 20% lower hazard). Over a 14-year follow-up, GG individuals also show higher rates of cognitive impairment compared to C-allele carriers.
The COPD signal (OR 1.99 for GG in a Russian cohort) aligns with FOXO3's critical role in lung oxidative stress defense: FOXO3 regulates catalase, MnSOD, and other antioxidant enzymes; lower expression in GG individuals leaves lung epithelium more vulnerable to oxidative injury from air pollution, smoking, and other stressors. This may partially explain the gene-environment interaction found with air pollution exposure.
Importantly, lifestyle interventions can substantially compensate for lower baseline FOXO3 expression: fasting, aerobic exercise, and cold exposure activate FOXO3 through AMPK and SIRT1 pathways independent of this variant's genotype.
Longevity-protective genotype with lower mortality and better cognitive aging
The CC genotype at rs2253310 marks individuals whose FOXO3 gene is most responsive to longevity-relevant stimuli in brain tissue. Two independent Chinese cohort studies (total n > 6,000) consistently show HR ~0.80 for mortality — a 20% survival advantage that accumulates over decades of follow-up. The eQTL signal in brain tissue is the strongest documented for rs2253310 among any tissue type, suggesting the variant's primary action is in neural FOXO3 regulation.
The cardiovascular benefit is also documented: among Japanese-American women, CC homozygotes had 6 mmHg lower systolic BP and essential hypertension prevalence of ~3% vs ~10% in GG women. This aligns with the FOXO3 pathway's known role in endothelial function and vascular aging.
Intermediate FOXO3 longevity protection with one C allele
With one C allele and one G allele, your FOXO3 expression at this eQTL is intermediate between the two homozygous states. The additive pattern seen in mortality studies implies that each C allele contributes roughly equal incremental protection — heterozygotes should expect roughly half the mortality benefit of CC homozygotes, or about 10% lower risk compared to GG individuals, though the study data are not powered to confirm this precisely.
The cognitive and cardiovascular data for heterozygotes are less characterized than for homozygotes; most studies report homozygous effects due to sample size constraints.
Key References
Ji et al. 2022 — 3,085 Chinese older adults; CC homozygotes had 19% lower mortality risk vs GG (HR 0.808, 95% CI 0.667–0.978) in gene-environment interaction analysis
Liu et al. 2021 — 3,179 Chinese adults aged 65+; two minor allele carriers had HR 0.803 (95% CI 0.666–0.968) for mortality; gene-environment interaction with residential greenness
Ji et al. 2022 — 14-year longitudinal Chinese cohort; homozygous minor allele carriers had lower odds of cognitive impairment; protective effects strongest in females and those in lower air-pollution areas
Bae et al. 2018 — meta-analysis of four centenarian cohorts (n=8,266); rs2253310 replicated as longevity-associated variant with most significant effect on FOXO3 expression in brain tissue among all 17 tested FOXO3 SNPs
Morris et al. 2016 — 843 Japanese-Americans; women homozygous for minor C allele had 6 mmHg lower systolic BP and 3 mmHg lower diastolic BP vs major allele homozygotes; essential hypertension prevalence 3.3% vs 9.5% (P = 0.03)
Markelov et al. 2025 — 1,365 Russians; GG genotype (homozygous risk allele) associated with 1.99-fold higher COPD risk (Padj = 5.93×10⁻⁷), confirming G allele as functionally adverse